LEADER 01619nam--2200433---4500
001 990000592190203316
005 20080305130755.0
010   $a92-9168-182-2
035   $a0059219
035   $aUSA010059219
035   $a(ALEPH)000059219USA01
035   $a0059219
100   $a20010828a20049999km-y0ITAy0103----ba
101   $aeng
102   $aLU
110   $aayyz---||||
200 1 $aReport on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs$fEuropean monitoring centre for drugs and drug addiction
210   $aLuxembourg$cOffice for official publications of the European Communities$d2004
215   $a74 p.$cill.$d21 cm
225 2 $aEMCDDA Risk assessments$v7
410  0$12001$aEMCDDA Risk assessments$v7
606 0 $aDroghe$xConsumo$xPrevenzione$xValutazione$yPaesi della Comunità europea
676   $a362.2937094
699   $a15.05$bNarcotici
712 02$aOSSERVATORIO EUROPEO DELLE DROGHE E DELLE TOSSICODIPENDENZE
801  0$aIT$bsalbc$gISBD
912   $a990000592190203316
951   $aCDE 15.05 (IV)$b12569 E.C.$cCDE 15.05$d00134954
959   $aBK
969   $aCDE
979   $aPATRY$b90$c20010828$lUSA01$h1354
979   $c20020403$lUSA01$h1708
979   $aPATRY$b90$c20040406$lUSA01$h1641
979   $aCDE$b90$c20050801$lUSA01$h1240
979   $aMARIAS$b90$c20080220$lUSA01$h1236
979   $aMARIAS$b90$c20080305$lUSA01$h1220
979   $aMARIAS$b90$c20080305$lUSA01$h1307
996   $aReport on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs$9883112
997   $aUNISA